Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Alamo Group Inc. (ALG) is a global industrial equipment company. The Zacks Consensus Estimate for its current year earnings has been revised 6.8% downward over the last 60 days.Ashtead Group plc (ASHTY) is an equipment leasing company. The Zacks Consensus Estimate for its current year earnings has been revised 6.9% downward over the last 60 days.Clear Secure, Inc. (YOU) is a digital identity verification company.The Zacks Consensus Es ...

SEGUIN, Texas, Dec. 20, 2024 /PRNewswire/ -- Alamo Group Inc. (NYSE: ALG) announced today that Jeff Leonard, the Company's President and CEO, has informed the Board of Directors of his intention to retire preferably by mid-year 2025 and upon the appointment of his successor. As part of its succession planning efforts, the Company's Board of Directors has been preparing for such a transition and anticipates naming a new President and CEO as Mr. Leonard's replacement within the next several months.  In announ ...

AUBURN HILLS, Mich., Nov. 19, 2024 /PRNewswire/ --  All-new Dodge Charger Daytona, the next generation of American muscle and the first all-electric vehicle from the Dodge brand, achieves highest residual value in J.D. Power's new electric car segment Jeep® Gladiator ranks No. 1 for residual value among midsize pickups, marking the third time Gladiator has earned a J.D. Power award* Jeep Wagoneer earns award for best residual value among large SUVs for third consecutive year Jeep Wrangler, Grand Cherokee, W ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:A-Mark Precious Metals, Inc. (AMRK) is a precious metals trading company. The Zacks Consensus Estimate for its current year earnings has been revised 17.5% downward over the last 60 days.Anika Therapeutics, Inc. (ANIK) is a joint preservation company. The Zacks Consensus Estimate for its current year earnings has been revised 82.8% downward over the last 60 days.Alamo Group Inc. (ALG) is a vegetation management and maintenance equipme ...

Alamo Group Inc (NYSE:ALG) Q3 2024 Earnings Conference Call November 1, 2024 10:00 AM ET Company Participants Edward Rizzuti - Executive Vice President, General Counsel and Secretary Jeff Leonard - President and Chief Executive Officer Agnes Kamps - Executive Vice President, Chief Financial Officer, and Treasurer Conference Call Participants Mike Shlisky - D.A. Davidson Chris Moore - CJS Securities Mig Dobre - Baird Greg Burns - Sidoti & Company Operator Good day, and welcome to the Alamo Group Inc. Third Q ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____ TO ____ Commission file number 0-21220 ALAMO GROUP INC. (Exact name of registrant as specified in its charter) Delaware 74-1621248 (State or other jurisdiction ...

| --- | --- | --- | |-------|----------|----------------------------------------| | | For: | Alamo Group Inc. | | | Contact: | Agnes Kamps | | | | Executive Vice President & CFO | | | | 830-372-9615 | | | | Financial Relations Board | | | | Joe Calabrese | | | | 212-827-3772 | ALAMO GROUP ANNOUNCES THIRD QUARTER FINANCIAL RESULTS AND COST REDUCTION ACTIONS SEGUIN, Texas, October 31, 2024 -- Alamo Group Inc. (NYSE: ALG) today reported results for the third quarter ended September 30, 2024. Highlights for the ...

ALG-055009 dose groups met the primary endpoint with statistically significant reductions in liver fat at Week 12 as measured by MRI-PDFFPlacebo-adjusted median relative reductions in liver fat were up to 46.2% with a clear dose responseALG-055009 was well-tolerated with no serious adverse events or dose reductions. Importantly, ALG-055009 dose groups had a similar incidence of gastrointestinal-related adverse events with less diarrhea compared to placeboSignificant reductions in atherogenic lipids, includi ...

SOUTH SAN FRANCISCO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Company will share the topline results from the Phase 2a HERALD study of ALG-055009, a thyroid hormone receptor beta (THR-β) agonist, in metabolic-dysfunction associated steatohepatitis (MASH) subjects on Thursday, Se ...

SimonSkafar/E+ via Getty Images Thesis Alamo Group (NYSE:ALG) is a leading global provider of high-quality equipment for infrastructure maintenance, agriculture and vegetation that has seen its stock price fall over the most recent months. The company remains a well-run, stable business however and boasts strong fundamentals. It is geographically well diversified and allocates capital more efficient than its near-competitors. Revenue and margins are steadily expanding over the years, which, I think, mak ...